AI-generated summary
The authors report a randomized trial of 75 patients with major depression, all taking duloxetine, who received either a chronotherapeutic program (wake therapy, daily bright light, sleep stabilization) or daily exercise. At week 29, remission was higher in the chronotherapy group (61.9% vs. 37.9%), with lower HAM-D17 scores, though the abstract reports only this single trial and the follow-up phase allowed medication changes.
- Participants
- 75
- Who or what was studied
- Adults with major depression receiving fixed-dose duloxetine
- Limits stated in the abstract
- The abstract reports a single trial in which medication could be altered during the follow-up phase, and it does not describe a placebo or sham control for the light therapy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy, Randomized controlled trial, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.